Alkermes plc. Treasury Stock, Value
Alkermes plc. (ALKS) had Treasury Stock, Value of $61.96 million as of 2016-03-31, per its 10-Q filed 2016-04-28.
Discontinued › Balance Sheet
us-gaap:TreasuryStockValue · last filed 2016-04-28
- 2016-03-31: Treasury Stock, Value $61.96M.
- 2015-12-31: Treasury Stock, Value $58.66M.
- 2015-09-30: Treasury Stock, Value $49.60M.
- 2015-06-30: Treasury Stock, Value $49.38M.
| Period end | Treasury Stock, Value |
|---|---|
| 2016-03-31 | $61.96M 10-Q · filed 2016-04-28 |
| 2015-12-31 | $58.66M 10-Q · filed 2016-04-28 |
| 2015-09-30 | $49.60M 10-Q · filed 2015-10-29 |
| 2015-06-30 | $49.38M 10-Q · filed 2015-07-30 |
| 2015-03-31 | $36.75M 10-Q · filed 2015-04-30 |
| 2014-12-31 | $32.05M 10-K · filed 2016-02-25 |
| 2014-09-30 | $30.88M 10-Q · filed 2014-10-29 |
| 2014-06-30 | $30.86M 10-Q · filed 2014-07-31 |
| 2014-03-31 | $17.96M 10-Q · filed 2014-04-30 |
| 2013-12-31 | $17.83M 10-K · filed 2015-02-24 |
| 2013-09-30 | $14.40M 10-Q · filed 2013-10-31 |
| 2013-06-30 | $13.90M 10-Q · filed 2013-07-25 |
| 2013-03-31 | $5.38M 10-KT · filed 2014-02-27 |
| 2012-12-31 | $5.38M 10-Q · filed 2013-01-31 |
| 2012-09-30 | $3.89M 10-Q · filed 2012-11-01 |
| 2012-06-30 | $3.89M 10-Q · filed 2012-07-26 |
| 2012-03-31 | $571.00K 10-K · filed 2013-05-23 |
| 2011-12-31 | $417.00K 10-Q · filed 2012-02-02 |
| 2011-09-30 | $0.00 10-Q · filed 2011-11-03 |
| 2011-03-31 | $131.09M 10-K · filed 2012-05-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |